Skip to content
OpenCapital
Get started

Ultragenyx Pharmaceutical RARE SG&A

SG&A at other companies

Eli Lilly logo
Eli LillyLLY
$2.93B+18.9%
Amgen logo
AmgenAMGN
$1.6B-5.0%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$150.36M+97.2%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$163.9M+54.1%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$49.32M+5.1%
Arrowhead Research logo
Arrowhead ResearchARWR
——

Other financials

Income statement

See full
Revenue$136.0M-2.2%
Operating income-$169.0M-18.2%
Net income-$185.0M-22.5%
EPS (diluted)-$1.84-17.2%

Balance sheet

See full
Cash & equivalents$175.0M+37.8%
Total debt$36.0M-10.8%
Total equity-$236.0M-264%
Total assets$1.3B-1.2%

Cash flow

See full
Operating cash flow-$197.0M-18.7%
CapEx$1.0M0.0%
Free cash flow-$198.0M-18.6%

Valuation

See full
Market cap$2.83B-39.4%
P/S4.2×-3.7×

Profitability

See full
Gross margin97.2%—
Operating margin-83.8%-3.0pp
Net margin-90.9%-2.1pp
FCF margin-75.1%+10.7pp

Returns & leverage

See full
Return on equity-325.6%+36.9pp
Debt / equity3.7×—
Current ratio2×-0.4×

Where this comes from

Reported directly by Ultragenyx Pharmaceutical in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ultragenyx Pharmaceutical's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ultragenyx Pharmaceutical's SG&A?
Ultragenyx Pharmaceutical (RARE) reported SG&A of $88M in Q1 2026.
How has Ultragenyx Pharmaceutical's SG&A changed year-over-year?
Ultragenyx Pharmaceutical's SG&A increased by 1.1% year-over-year, from $87M to $88M.
What is the long-term trend for Ultragenyx Pharmaceutical's SG&A?
Over 4 years (2021 to 2025), Ultragenyx Pharmaceutical's SG&A has grown at a 12.2% compound annual growth rate (CAGR), from $219.98M to $348.2M.
What does SG&A mean?
Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.